|
FASTKD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.835400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.325200E-01 |
| Normal-vs-Stage2 |
3.543200E-01 |
| Normal-vs-Stage3 |
6.632000E-01 |
| Normal-vs-Stage4 |
6.425000E-01 |
| Stage1-vs-Stage2 |
5.397700E-02 |
| Stage1-vs-Stage3 |
2.451200E-01 |
| Stage1-vs-Stage4 |
2.654200E-01 |
| Stage2-vs-Stage3 |
7.016200E-01 |
| Stage2-vs-Stage4 |
8.233200E-01 |
| Stage3-vs-Stage4 |
9.394200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.806400E-01 |
| Normal-vs-AfricanAmerican |
2.116000E-01 |
| Normal-vs-Asian |
2.527000E-01 |
| Caucasian-vs-AfricanAmerican |
2.008400E-01 |
| Caucasian-vs-Asian |
2.112200E-01 |
| AfricanAmerican-vs-Asian |
6.840200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.218800E-01 |
| Normal-vs-Female |
5.350400E-01 |
| Male-vs-Female |
8.094000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.478200E-01 |
| Normal-vs-Extreme_Weight |
6.547800E-01 |
| Normal-vs-Obese |
3.364000E-01 |
| Normal-vs-Extreme_Obese |
8.907800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.012200E-01 |
| Normal_Weight-vs-Obese |
4.451400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.227800E-01 |
| Extreme_Weight-vs-Obese |
4.394800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.729000E-01 |
| Obese-vs-Extreme_Obese |
4.644800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.088400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.968600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.139200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.381000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.204200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.018800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.524600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.405200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.420200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.503400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.935200E-01 |
| Normal-VS-Type2 PRCC |
8.859600E-01 |
| Normal-VS-KIRP CIMP |
1.576540E-03 |
| Normal-VS-Unclassified PRCC |
7.598400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.551400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.845600E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.451400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.704500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.672000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.491670E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.287600E-01 |
| Normal-vs-N1 |
8.665800E-01 |
| Normal-vs-N2 |
1.027400E-01 |
| N0-vs-N1 |
7.770800E-01 |
| N0-vs-N2 |
9.406500E-02 |
| N1-vs-N2 |
2.735000E-01 |
|
|
